COVID-19: Joint statement from ECDC and EMA on the administration of a fourth dose of mRNA vaccines.
7 Apr, 2022 | 10:00h | UTCRelated:
Perspective: The evidence on 4th doses of covid vaccines & the thorny question of age thresholds.
U.S. approves second Covid-19 booster for people 50 and older and immunocompromised individuals.
[Preprint] Fourth dose of COVID vaccine offers only slight boost against Omicron infection.
Covid-19: Fourth vaccine doses—who needs them and why?
[Not published yet] Study in Israel finds fourth COVID booster has limited efficacy.
Commentary on Twitter (thread – click for more)
#JustPublished!#ECDC and @EMA_News issue advice on fourth doses of mRNA #COVID19 vaccines.
Read the full joint statement: https://t.co/hBuOlrfKOD pic.twitter.com/aO5vSyYvTk
— ECDC (@ECDC_EU) April 6, 2022